Santos da Silva Jorge
Chief Executive Officer at MLTX
- Sold, on record
- $19.2M
- Dollars the filings state
- Form 4 sales
- 7
- Latest Jul 10, 2026
- Form 144 notices
- 4
- Proposed sales
- Companies
- 1
- Filed as an executive or holder
Companies
- MLTXMoonLake ImmunotherapeuticsChief Executive Officer
Sales by reason
Form 4 sales per month, last 12 months.
Timeline
- 1 Form 4 sale MLTXRoutineFeb 29, 2024 2024
Sold 123,615 shares at $55.03 ($6.8M)
Santos da Silva Jorge, Chief Executive Officer
10b5-1 planSold 4% of holdings ($171M position)3M shares leftFollows a Form 144Filing
- 2 Form 144 notice MLTXNoticeDec 8, 2025 +648 days
Filed to sell 200,000 shares ($3M)
Santos da Silva Jorge, Officer, Director, CEO
No 10b5-1 plan3.3x usual sizeFiling
- 3 Form 4 sale MLTXUnusualDec 9, 2025 +1 day
Sold 200,000 shares at $14.87 ($3M)
Santos da Silva Jorge, Chief Executive Officer
No 10b5-1 planSold 6.5% of holdings ($45.8M position)2.9M shares left3.3x usual sizeFollows a Form 144Filing
- 4 Form 144 notice MLTXNoticeApr 10, 2026 +122 days
Filed to sell 150,000 shares ($2.8M)
No 10b5-1 planFiling
- 5 Form 4 sale MLTXNo planApr 13, 2026 +3 days
Sold 150,000 shares at $18.35 ($2.8M)
Santos da Silva Jorge, Chief Executive Officer
No 10b5-1 planSold 4.9% of holdings ($56.4M position)2.9M shares leftFollows a Form 144Filing
- 6 Form 144 notice MLTXNoticeJun 30, 2026 +78 days
Filed to sell 150,000 shares ($3M)
Santos da Silva Jorge, Officer, CEO
10b5-1 planFiling
- 7 Form 4 sale MLTXRoutineJul 1, 2026 +1 day
Sold 47,775 shares at $20.03 ($957k)
Santos da Silva Jorge, Chief Executive Officer
10b5-1 planSold 1.6% of holdings ($58.6M position)2.9M shares leftFollows a Form 144Filing
- 8 Form 4 sale MLTXRoutineJul 10, 2026 +9 days
Sold 102,225 shares at $20.02 ($2M)
Santos da Silva Jorge, Chief Executive Officer
10b5-1 planSold 3.6% of holdings ($57.6M position)2.8M shares left0.7x usual sizeFollows a Form 144Filing
Every transaction
Loading transactions…
Sales and notices (11)
| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Jul 10, 2026 | Jul 13, 2026 | MLTX | Chief Executive Officer | Form 4 sale | 102,225 | $2M | 3.6% | Routine | SEC |
| Jul 1, 2026 | Jul 2, 2026 | MLTX | Chief Executive Officer | Form 4 sale | 47,775 | $957k | 1.6% | Routine | SEC |
| Jun 30, 2026 | Jun 30, 2026 | MLTX | Officer, CEO | Form 144 notice | 150,000 | $3M | Notice | SEC | |
| Apr 13, 2026 | Apr 14, 2026 | MLTX | Chief Executive Officer | Form 4 sale | 150,000 | $2.8M | 4.9% | No plan | SEC |
| Apr 10, 2026 | Apr 10, 2026 | MLTX | CEO | Form 144 notice | 150,000 | $2.8M | Notice | SEC | |
| Dec 9, 2025 | Dec 10, 2025 | MLTX | Chief Executive Officer | Form 4 sale | 200,000 | $3M | 6.5% | Unusual | SEC |
| Dec 8, 2025 | Dec 8, 2025 | MLTX | Officer, Director, CEO | Form 144 notice | 200,000 | $3M | Notice | SEC | |
| Feb 29, 2024 | Feb 29, 2024 | MLTX | Chief Executive Officer | Form 4 sale | 123,615 | $6.8M | 4.0% | Routine | SEC |
| Feb 21, 2024 | Feb 23, 2024 | MLTX | Chief Executive Officer | Form 4 sale | 1,125 | $62k | 0.0% | Routine | SEC |
| Feb 20, 2024 | Feb 20, 2024 | MLTX | Chief Executive Officer | Form 4 sale | 60,000 | $3.6M | 1.9% | Routine | SEC |
| Feb 15, 2024 | Feb 15, 2024 | MLTX | CEO | Form 144 notice | 200,000 | $12.8M | Notice | SEC |